RIG has rallied 11% this week and now trades at $5.81, yet short sellers are adding to positions rather than retreating — a tension worth examining after a Q2 print that barely moved the needle.
The most striking development in positioning is the acceleration in short interest despite the price recovery. Short interest has climbed to 23.5% of the free float — up from 22.6% before the August 6 earnings release flagged in our prior note, and now running some 21% higher than a month ago. The latest ORTEX estimate puts shares short at roughly 259 million, a step up from the 247-248 million range that prevailed through most of late July and early August. Yet bears face almost no structural pressure to cover: borrowing costs have eased to 0.44%, down nearly 16% on the week, and the borrow market remains decidedly loose with availability at 355% — meaning more than three-and-a-half shares are available to borrow for every one already lent out. That compares with a 52-week tightest reading of 112%, so there is no squeeze dynamic forming anywhere on the horizon. Options traders are similarly unbothered. The put/call ratio of 0.62 runs slightly below its 20-day average of 0.66, with a z-score of -1.15 — fractionally more call-heavy than usual, but nothing that signals conviction either way. Positioning, in aggregate, reads as a crowded short with the door wide open to add more.
The Street is quietly trimming its optimism. Barclays maintained an Overweight rating this morning but lowered its target from $8 to $7 — a signal that the bull case is intact but needing adjustment after Q2. That $7 target is now roughly in line with the consensus mean of $6.52, suggesting the Street is clustering around a modest upside scenario from current levels rather than a rerating story. The ORTEX analyst recommendation factor score ranks at the 98th percentile, which reflects a positive skew in ratings relative to the universe — bulls are still in the majority. But the EPS surprise score of 91 tells the more interesting part: Transocean has been consistently beating estimates, and that operational delivery is part of what anchors the bull case. Against that, valuation multiples are undemanding — EV/EBITDA at 8.6x and price-to-book below 0.75x — but the quality and value pillars in the ORTEX composite score remain weak at sub-30 readings, and the short score of 66.1 keeps RIG firmly in the bottom decile of its sector for bearish pressure.
The week's sector move adds some colour. Closest peer VAL gained 11.1% on the week, nearly matching RIG's advance, while NE rose 8.9% and SDRL added around 9.9%. The rally is clearly sector-wide rather than RIG-specific — energy names broadly caught a bid — which makes the simultaneous build in short interest particularly notable. Bears are treating the rally as a selling opportunity rather than evidence the thesis is broken.
On the institutional side, the ownership picture shows a mix of passive and active money. BlackRock added 3.6 million shares through July, Dimensional added 5.3 million, and Capital Research built a further 13.9 million-share position through June. Against that, the most recent insider activity worth noting is a modest open-market purchase by Lead Independent Director Chad Deaton on July 2 — 35,000 shares at $4.95, worth roughly $173,000. It is not a large transaction in absolute terms, but it came below the current price and is the only outright buy among recent insider activity. Prior months saw routine award-and-sell patterns among directors and the CLO, none of which carry directional signal.
The next scheduled catalyst is Q3 earnings, currently flagged for October 26. Between now and then, the key variable is whether the borrow market begins to tighten as short interest continues building — currently availability remains too wide to matter, but if shares short push materially above 260 million and the borrow pool does not expand proportionally, that gap will narrow.
See the live data behind this article on ORTEX.
Open RIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
